A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotere(Ⓡ) (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy

BACKGROUND: Docetaxel is a clinically well established antimitotic chemotherapy medication. Labeled docetaxel indications are breast cancer, gastric cancer, head and neck cancer, non–small cell lung cancer, and prostate cancer. OBJECTIVE: This is a Phase IV study to evaluate the safety profile of do...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahi, Farhad, Vafaeezadeh, Farahnaz, Ansarinejad, Nafiseh, Ahmadi, Alireza, Shahriari-Ahmadi, Ali, Ghazizadeh, Alireza, Vahedian Ardakani, Hassanali, Ravanbod, Mohammad Reza, Seifi, Sharareh, Foratyazdi, Mohammad, Mousavi, Seyed Asadollah, Rajabi Vahid, Mansour, Rahimi, Hossein, Seghatoleslami, Mohammad, Razavi, Seyed Mohsen, Pourkhani, Amir Houshang, Babakhani, Davoud, Anjidani, Nassim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749121/
https://www.ncbi.nlm.nih.gov/pubmed/35035631
http://dx.doi.org/10.1016/j.curtheres.2021.100659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749121/
https://www.ncbi.nlm.nih.gov/pubmed/35035631
http://dx.doi.org/10.1016/j.curtheres.2021.100659

Ejemplares similares